242 related articles for article (PubMed ID: 9623101)
1. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy].
Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R
Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101
[TBL] [Abstract][Full Text] [Related]
2. The treatment of masseter hypertrophy with botulinum toxin type A.
Al-Ahmad HT; Al-Qudah MA
Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
[TBL] [Abstract][Full Text] [Related]
3. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
Işeri M; Işeri PK
Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109
[TBL] [Abstract][Full Text] [Related]
4. The medical management of masseteric hypertrophy with botulinum toxin.
Finn S; Ryan P; Sleeman D
J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin as an alternative for the treatment of aesthetic deformities.
Barbosa MV; Nahas FX; Ferreira LM; Al-Ahmad HT; Al-Qudah M
Saudi Med J; 2006 Oct; 27(10):1613; author reply 1613. PubMed ID: 17013500
[No Abstract] [Full Text] [Related]
6. Lower facial contouring with botulinum toxin type A.
Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A treatment for contouring of the lower leg.
Han KH; Joo YH; Moon SE; Kim KH
J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
[TBL] [Abstract][Full Text] [Related]
8. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
Baş B; Ozan B; Muğlali M; Celebi N
Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
[TBL] [Abstract][Full Text] [Related]
9. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
Tsai CY; Chiu WC; Liao YH; Tsai CM
Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
[TBL] [Abstract][Full Text] [Related]
10. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width.
Wu WT
Facial Plast Surg Clin North Am; 2010 Feb; 18(1):133-40. PubMed ID: 20206096
[TBL] [Abstract][Full Text] [Related]
11. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
Kwon JS; Kim ST; Jeon YM; Choi JH
Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
[TBL] [Abstract][Full Text] [Related]
12. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle.
Kim JH; Shin JH; Kim ST; Kim CY
Plast Reconstr Surg; 2007 Feb; 119(2):711-7. PubMed ID: 17230111
[TBL] [Abstract][Full Text] [Related]
13. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.
El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P
Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443
[TBL] [Abstract][Full Text] [Related]
14. Botulism toxin: use in disorders of the temporomandibular joint.
Chang H
Dent Today; 2005 Dec; 24(12):48, 50-1; quiz 51. PubMed ID: 16396158
[No Abstract] [Full Text] [Related]
15. [Asymmetric hypertrophy of the masticatory muscles].
Arzul L; Corre P; Khonsari RH; Mercier JM; Piot B
Ann Chir Plast Esthet; 2012 Jun; 57(3):286-91. PubMed ID: 22455902
[TBL] [Abstract][Full Text] [Related]
16. The use of botulinum toxin for the treatment of temporomandibular disorder.
Freund B; Schwartz M
Oral Health; 1998 Feb; 88(2):32-7. PubMed ID: 9610334
[No Abstract] [Full Text] [Related]
17. Botulinum toxin for masseter hypertrophy.
Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe bruxism with botulinum toxin type A].
Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A treatment for contouring of the lower face.
Park MY; Ahn KY; Jung DS
Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular nerve distribution of the masseter muscle as a basis for botulinum toxin injection.
Kim DH; Hong HS; Won SY; Kim HJ; Hu KS; Choi JH; Kim HJ
J Craniofac Surg; 2010 Mar; 21(2):588-91. PubMed ID: 20489458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
